Trueblue (TBI) Proxy Filing summary
Event summary combining transcript, slides, and related documents.
Proxy Filing summary
2 Dec, 2025Executive summary
Two new independent directors, William Greenblatt and William Seward, were appointed to the board, effective January 5, 2026, following an extensive search and shareholder input.
The board will return to a size of nine directors after the 2026 Annual Meeting, with two current directors expected to step down as part of ongoing board refreshment.
The appointments are intended to strengthen operational oversight, accelerate growth, and align with strategic priorities for long-term shareholder value.
Forward-looking statements highlight expectations for growth, digital investments, and ongoing risk factors affecting future performance.
Voting matters and shareholder proposals
The company will file a proxy statement and related materials for the 2026 annual meeting, encouraging shareholders to review these documents for important information.
All directors and certain executive officers are considered participants in the proxy solicitation for the 2026 annual meeting.
Board of directors and corporate governance
William Greenblatt brings expertise in background screening and business services, while William Seward offers deep experience in logistics and operations.
The board refreshment program aims to enhance diversity of experience and strengthen oversight in technology, workforce solutions, and operations.
Eight of the nine directors expected after the 2026 Annual Meeting will be independent.
Latest events from Trueblue
- Board refreshment and profitability initiatives advance as proxy contest with EHS continues.TBI
Proxy Filing3 Mar 2026 - Revenue up 8% to $418M, but net loss widened on impairment; margin pressure persists.TBI
Q4 202518 Feb 2026 - Q2 revenue down 17% to $396M, net loss $105M, with cost cuts and digital focus amid uncertainty.TBI
Q2 20242 Feb 2026 - Digital innovation and market expansion drive growth and margin gains in a fragmented staffing sector.TBI
Sidoti September Small-Cap Virtual Conference20 Jan 2026 - Q3 revenue dropped 19.2% with a $59.1M goodwill impairment and strong cost controls.TBI
Q3 202416 Jan 2026 - Board refreshment and strategic initiatives position the company for long-term growth.TBI
Proxy Filing9 Jan 2026 - Board refreshment and strategic focus highlighted as proxy process begins for 2026.TBI
Proxy Filing9 Jan 2026 - Q4 revenue fell 22% but margin gains, cost cuts, and healthcare expansion support recovery.TBI
Q4 202424 Dec 2025 - Shareholders will vote on directors, executive pay, incentive plan, and auditor, with strong governance and ESG focus.TBI
Proxy Filing1 Dec 2025